CCES 2015 CCES vs Daniel Novia

In July 2015 the Canadian Centre for Ethics in Sport (CCES) reported an anti-doping rule violation against the Athlete Daniel Novia after his A and B samples tested positive for the prohibited susbstances Methasterone, Tamoxifen and Testosterone.

After notification the Athlete gave a prompt admission, waived his right to be heard, accepted a provisional suspension and the sanction proposed by the CCES.

The Athlete stated that the violation was not intentional, that he had used supplements provided by a friend and that these supplements must have contained the prohibited substances. He explained that he was 'retired' when he used these supplements and he stopped using these supplements once selected to the Pan Am Games team.

The CCES has significant concerns about the Athlete's explanation due to he failed to produce the supplements in question and consequently they could not be tested. Due to the Athlete waived his right for a hearing it was impossible to determine a reduction of his sanction on the basis of his degree of fault.

Nevertheless WADA and CCES agree that the Athlete should be afforded a reduction of 4 months of the period of ineligibility for his waiver for his right to a hearing.
Therefore the CCES decides on 16 September 2015 to impose a 3 year and 8 month period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. on 15 July 2015.

Original document

Parameters

Legal Source
National Decisions
Date
16 September 2015
Original Source
Canadian Centre for Ethics in Sport (CCES)
Country
Canada
Language
English
ADRV
Adverse Analytical Finding / presence
Legal Terms
Acceptance of sanction
Burdens and standards of proof
Circumstantial evidence
Period of ineligibility
Prompt / Timely Admission
Waiver of "right to be heard"
Sport/IFs
Athletics (WA) - World Athletics
Other organisations
Canadian Centre for Ethics in Sport (CCES)
Canadian Cycling Association (CCA) - Association Cycliste Canadienne ( ACC)
Laboratories
Montreal, Canada: Laboratoire de controle du dopage INRS-Institut Armand-Frappier
Analytical aspects
B sample analysis
Doping classes
S1. Anabolic Agents
S4. Hormone And Metabolic Modulators
Substances
Methasterone (17β-hydroxy-2α,17α-dimethyl-5α-androstan-3-one)
Tamoxifen
Testosterone
Various
Retirement
Supplements
Document type
Pdf file
Date generated
12 November 2015
Date of last modification
14 June 2021
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin